Skip to main content

Table 2 Summary of censored data for outcome variables

From: Clinical outcomes and cost-effectiveness of collaborative treatment with Korean and Western medicine in patients with facial palsy: a multicenter prospective observational study

Variables

Never censored

Ever censored

Total

Participant, n (%)

   

UC

42 (93)

3 (7)

45 (100)

CT

76 (89)

9 (11)

85 (100)

Total

118 (91)

12 (9)

130 (100)

Periods with data observation, n

   

UC

504

12

516

CT

912

60

972

Total

1416

72

1488

Periods with data available, n (%)

   

UC

504 (100)

36 (33)

540 (96)

CT

912 (100)

108 (56)

1020 (95)

Total

1416 (100)

144 (50)

1560 (95)

Periods with censored data, %

0

50

5

 

Chi-square distance

p-value

MCAR test result

 

5.09

0.28

MCAR (CDM) test result

 

31.81

0.67

  1. UC, usual care; CT, collaborative treatment; MCAR, missing completely at random; CDM, covariate-dependent missingness; n, frequency